Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,562.10
-7.6628-0.49%
Number of Gainers:- -
Number of Losers:7
Number of Flat:- -
PE:- -
High:1,579.75
Open:1,579.75
Low:1,560.69
Close:1,569.77
Volume:27.72M
Turnover:2.75B
Market Cap:1.63T
Float Cap:1.56T

Loading ...

Structure Therapeutics - First Participants Dosed with Accg-2671 in 12-Week Mad Phase 1/2a Trial; Topline Data Expected 1H 2027

THOMSON REUTERS
·
Sep 08

【US Pre-Market】Middle East Energy Risks Escalate, Brent Crude Nears $100, Oil and Gas Stocks Rise; Novartis Plunges 13%

TradingKey
·
Sep 08

Intel, Amgen, Novartis, Bloom Energy, and More Stocks That Explain Today's Market

Dow Jones
·
Sep 08

Plastic Surgery is Booming with Boomers. Here's How to Cash in on the Antiaging Craze.

Dow Jones
·
Sep 08

Beneath the Surface, the Next Market Leaders are Getting Ready to Break Out, Says Morgan Stanley

Dow Jones
·
Sep 08

Ionis Pharma Tumbles After Heart Drug Fails Late-Stage Trial

Reuters
·
Sep 08

Beam Therapeutics Presents Updated Clinical Data from the Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the European Respiratory Society (ERS) Congress 2026

GlobeNewswire
·
Sep 08

Why Amgen Stock is Dropping After Swiss Rival's Trial Setback

Dow Jones
·
Sep 08

Amgen Falls After Novartis Trial Setback, BMO Downgrade

Reuters
·
Sep 08

Novo Nordisk Phase 3 Trial Meets Primary Endpoint for Child Obesity Drug

MT Newswires Live
·
Sep 08

Stocks to Watch: Amgen, Nike, Bloom Energy

Dow Jones
·
Sep 08

Market Chatter: Novo Nordisk Halts Two More Ziltivekimab Trials

MT Newswires Live
·
Sep 08

Amgen Shares Down 5.4% Premarket; Rival Novartis Cholesterol Drug Fails Late-Stage Study

THOMSON REUTERS
·
Sep 08

Why the Dow is Being Dragged Down by a Swiss Company's Bad News

Dow Jones
·
Sep 08

AlzeCure Pharma to Present at Aktiedagen Event in Stockholm

Reuters
·
Sep 08

Novo Nordisk (0QIU) Receives a Hold from Barclays

TIPRANKS
·
Sep 08

Novo Nordisk halts two trials testing ziltivekimab, Bloomberg reports

TIPRANKS
·
Sep 08

Yen advances to six-month high, chip stocks rise

Nicholas Reynolds / Bloomberg
·
Sep 08

Novo Nordisk announces STEP Young phase 3 trial met its primary endpoint

TIPRANKS
·
Sep 08

Novo Nordisk (NVO) Hit by Another Heart Drug Setback

TIPRANKS
·
Sep 08